Venlafaxine
Payments companies reported to CMS as associated with Venlafaxine. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Venlafaxine, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Venlafaxine
These are the largest totals companies reported as associated with Venlafaxine. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rigoberto Franco | Miami, FL | Internal Medicine | $61.04 |
| Jaime Alayo Villalobos | Miami, FL | Nurse Practitioner | $61.04 |
| David Lopez | Miami, FL | Family | $61.04 |
| Daniel Frutos | Miami Lakes, FL | Psychiatric/Mental Health (Nurse Practitioner) | $59.67 |
| Kettlyne Stcyr | West Park, FL | Family | $56.81 |
| John Jung | Miami, FL | Psychiatry | $56.81 |
| Michael Oros | Independence, OH | Addiction Psychiatry | $51.63 |
| Andre Guevara | Homestead, FL | Physician Assistant | $47.70 |
| Katheryn Fernandez Paul | Homestead, FL | Psychiatric/Mental Health (Nurse Practitioner) | $47.70 |
| Jacqueline Iriarte | Homestead, FL | Psychiatric/Mental Health (Nurse Practitioner) | $47.70 |
Prescribed Venlafaxine?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.